Research commercialisation in Australia has been getting more attention recently, but researchers face major obstacles to achieving this. If Australia wants to get serious about commercialising ...

FEINDEF 27 is expected to exceed 89,000 m² of total exhibition area, representing a 46% increase compared to 2025 and further strengthening its position as one of Europe’s leading international ...

23 Member and Associate States of the Agency pledged a total 117.6 million euros to ESA’s ScaleUp programme at ESA’s Ministerial Council CM22 to encourage entrepreneurship and commercialisation in the ...

The Western debate about China’s industrial rise fixates on subsidies, but the real driver is commercialisation: the ability to take technology from laboratory to global market faster than any ...

There is little doubt that the arrival of COVID-19 changed the game for communication and commercialisation efforts for pharmaceutical companies around the world. Cut off from tried and tested methods ...

Efforts to develop and commercialise nanotechnology face a variety of challenges: technical hurdles, availability of capital, environmental, health and safety concerns, and immature manufacturing ...

From universities to start-ups to science labs, Australia is a fertile ground for innovation. However, the one element of successful ­innovation constantly being overlooked is commercialisation.

OPINION:The university must help grow the economy – research turns money into knowledge, innovation turns knowledge into money, writes JOHN SCANLAN. SCIENCE FOUNDATION Ireland (SFI) was established in ...

The high-quality research conducted at the University of Helsinki and the innovations resulting from it are of far-reaching benefit to the society. Competitive innovations, commercialisation projects, ...

Universities will need to make some significant adjustments to meet the government’s targets in boosting the commercialisation of research. shutterstock The world’s most prosperous and advanced ...

The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. In some cases it was an accelerant for existing ...